Loading in 2 Seconds...
Loading in 2 Seconds...
Deep Brain Stimulation (DBS) is used for treating different neurological diseases ranging from dystonia, epilepsy, obsessive compulsive disorder to Parkinsonâ€™s disease. Rising awareness about neurological diseases along with the efficiency of accessing the brain through DBS is contributing to the market growth.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
by Technology, by Application and Segment Forecasts 2016- 2025
Deep Brain Stimulation (DBS) is used for treating different neurological diseases ranging from
dystonia, epilepsy, obsessive compulsive disorder to Parkinson’s disease. Rising awareness
about neurological diseases along with the efficiency of accessing the brain through DBS is
contributing to the market growth. As more professionals are adopting DBS over drug therapy to
avoid side effects, the market is expected to exhibit significant growth during the forecast period.
DBS can be used to restore movements in cases of neurological injuries that can result into
disability or paralysis. Also, DBS procedures have fewer complications as compared to
procedures such as pallidotomy owing to the non-destructive nature of the DBS procedures.
For more information, click on the below link @
A research study titled, “Deep Brain Stimulation Market by Application - Global Industry
Analysis and Forecast to 2025” published by Crystal Market Research, states that the deep brain
stimulation market is projected to be around $3.2billion by 2025.
Parkinson’s disease segment accounted for more than three-fourth share of the global DBS
market in 2016, due to growing prevalence of this disease. According to the Parkinson’s Disease
Foundation, around 60,000 patients are diagnosed with Parkinson’s disease every year in the
U.S. Men are one and a half times more susceptible to Parkinson’s disease as compared to
women. Although DBS is not a permanent cure for Parkinson’s disease it can surely control the
symptoms to a great extent improving the quality of life of the affected patients. According to
WHO, more than 50 million people across the world are suffering from epilepsy. DBS has
significant applications in the treatment of epilepsy by reducing the chances of a seizure.
1 | P a g e
North America held a significant share of the global deep brain stimulation market in 2016, due
to the presence of major vendors in the U.S. and advanced healthcare research and development
facilities conducting research on the treatment of neurological diseases. The Asia-Pacific DBS
market will show considerable growth during the forecast period. Deep brain stimulation
procedure acts as a minimally invasive alternative to long term administration of medication for
Parkinson’s patients. This could be beneficial with respect to affordability for patients in
Major Market Players:
Some of the key players in DBS market are St. Jude Medical, Medtronic Plc., Enteromedics,
Boston Scientific Corporation, Aleva Neurotherapeutics SA, Zynex, and Cyberonics.
Deep Brain Stimulation Market Segmentation:
By Application: Obsessive-Compulsive Disorder, Epilepsy, Parkinson’s Disease, Pain
Management, Dystonia, Depression, Others
Purchase the report @ https://www.crystalmarketresearch.com/checkout/HC058
About Crystal Market Research:
Crystal offers one stop solution for market research, business intelligence, and consulting
services to help clients make more informed decisions. It provides both syndicated as well as
customized research studies for its customers spread across the globe. The company offers
market intelligence reports across a broad range of industries including healthcare, chemicals &
materials, technology, automotive, and energy.
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107, United States.
Toll Free: +1-888-213-4282
2 | P a g e